UBS Maintains Neutral on Blend Labs, Lowers Price Target to $3.5

Benzinga · 08/08/2025 18:29
UBS analyst Karl Keirstead maintains Blend Labs (NYSE:BLND) with a Neutral and lowers the price target from $4 to $3.5.